triamterene has been researched along with Libman-Sacks Disease in 2 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kast, RE | 1 |
| Altschuler, EL | 1 |
| Berbis, P | 1 |
| Vernay-Vaisse, C | 1 |
| Privat, Y | 1 |
2 other studies available for triamterene and Libman-Sacks Disease
| Article | Year |
|---|---|
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells: consideration of triamterene to treat lupus.
Topics: B-Lymphocytes; Dendritic Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lupus Erythematosus, S | 2010 |
[Subacute cutaneous lupus observed during treatment with thiazide diuretics].
Topics: Aged; Benzothiadiazines; Diuretics; Drug Combinations; Female; Humans; Lupus Erythematosus, Systemic | 1986 |